Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Hoepner · SciRah

Researcher profile · Semantic Scholar

R. Hoepner

Share profile

R. Hoepner — researcher profile on SciRah

h-index: 25
Works: 165
Citations: 2,086

Most-cited papers

Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial.
C. Lebrun-Frénay, A. Siva, M. Sormani, C. Landes-Château +25 more
2023JAMA Neurology96 citations Open access
Semantic Scholar
Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B‐Cell Depleting Treatment in Multiple Sclerosis
P. Benkert, Aleksandra Maleska Maceski, S. Schaedelin, J. Oechtering +48 more
2024Annals of Neurology63 citations Open access
Semantic Scholar
GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis
A. Maceski, P. Benkert, M. Einsiedler, S. Schaedelin +47 more
2025Brain : a journal of neurology27 citations Open access
Semantic Scholar
Vaccine Hesitancy in Patients With Multiple Sclerosis
L. Diem, C. Friedli, A. Chan, A. Salmen +1 more
2021Neurology: Neuroimmunology & Neuroinflammation27 citations Open access
Semantic Scholar
Multidimensional phenotyping of the post‐COVID‐19 syndrome: A Swiss survey study
L. Diem, A. Schwarzwald, C. Friedli, H. Hammer +8 more
2022CNS Neuroscience & Therapeutics26 citations Open access
Semantic Scholar
Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19
L. Diem, Livia Fregolente-Gomes, J. Warncke, H. Hammer +9 more
2022Journal of Central Nervous System Disease26 citations Open access
Semantic Scholar
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome.
N. Fissolo, S. Schaedelin, L. Villar, J. Lünemann +54 more
2025JAMA Neurology25 citations Open access
Semantic Scholar
Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG–Associated Experimental Autoimmune Encephalomyelitis
J. Remlinger, Adrian Madarasz, Kirsten Guse, R. Hoepner +12 more
2022Neurology: Neuroimmunology & Neuroinflammation24 citations Open access
Semantic Scholar
Reliable brain morphometry from contrast‐enhanced T1w‐MRI in patients with multiple sclerosis
Michael Rebsamen, Richard McKinley, Piotr Radojewski, M. Pistor +8 more
2022Human Brain Mapping23 citations Open access
Semantic Scholar
Blood Biomarkers for Predicting Disability Worsening in Progressive Multiple Sclerosis: A Multinational, Individual Participant-Level Analysis
A. Abdelhak, F. Bachhuber, Kiarra Ning, P. Benkert +72 more
2025Journal of Neurology Neurosurgery & Psychiatry20 citations Open access
Semantic Scholar
MRI signs helpful in the differentiation of patients with anterior ischaemic optic neuropathy and optic neuritis
V. Petroulia, D. Brügger, R. Hoepner, Rino Vicini +3 more
2021British Journal of Ophthalmology20 citations
Semantic Scholar
Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age‐ and BMI‐Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment Response
M. Einsiedler, A. Maceski, S. Sandgren, J. Oechtering +39 more
2025Annals of Clinical and Translational Neurology18 citations Open access
Semantic Scholar
Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis
J. Oechtering, S. Schaedelin, Kerstin Stein, Aleksandra Maleska Maceski +34 more
2025Neurology(R) neuroimmunology & neuroinflammation18 citations Open access
Semantic Scholar
Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune-related adverse events among cancer patients
B. Özdemir, C. Espinosa da Silva, D. Arangalage, P. Monney +11 more
2023Cancer Immunology and Immunotherapy18 citations Open access
Semantic Scholar
Increased vision impairment reports linked to semaglutide: analysis of FDA adverse event data
Marine Massy, Stefanie Marti, H. Hammer, R. Hoepner
2025BMC Medicine16 citations Open access
Semantic Scholar
Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study
Ö. Yaldizli, P. Benkert, L. Achtnichts, Amit Bar-Or +39 more
2025Multiple Sclerosis15 citations Open access
Semantic Scholar
Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy
D. Sidler, A. Born, Simeon Schietzel, M. Horn +20 more
2022RMD Open15 citations Open access
Semantic Scholar
Sex and gender differences in autoimmune demyelinating CNS disorders: Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and myelin-oligodendrocyte-glycoprotein antibody associated disorder (MOGAD).
L. Diem, H. Hammer, R. Hoepner, M. Pistor +2 more
2022International review of neurobiology15 citations
Semantic Scholar
Ocrelizumab-related neutropenia: Effects of age, sex and bodyweight using the FDA Adverse Event Reporting System (FAERS).
H. Hammer, N. Kamber, M. Pistor, L. Diem +4 more
2022Multiple Sclerosis and Related Disorders14 citations
Semantic Scholar
Efficacy and safety of ocrelizumab in patients with relapsing multiple sclerosis: Real-world experience of two Swiss multiple sclerosis centers.
L. Diem, A. Ovchinnikov, C. Friedli, H. Hammer +5 more
2024Multiple Sclerosis and Related Disorders12 citations Open access
Semantic Scholar
Anti‐kelchlike protein 11 antibody‐associated encephalitis: Two case reports and review of the literature
Alejandro León Betancourt, Anina Schwarzwald, A. Millonig, M. Oberholzer +8 more
2023European Journal of Neurology12 citations Open access
Semantic Scholar
Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patients
C. Friedli, F. Wagner, H. Hammer, N. Kamber +5 more
2022Multiple Sclerosis12 citations
Semantic Scholar
Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses
B. Wipke, R. Hoepner, K. Straßburger-krogias, Ankur M. Thomas +7 more
2021Neurology: Neuroimmunology & Neuroinflammation12 citations Open access
Semantic Scholar
Growing importance of brain morphometry analysis in the clinical routine: The hidden impact of MR sequence parameters.
Michael Rebsamen, M. Capiglioni, R. Hoepner, A. Salmen +3 more
2023Journal of neuroradiology = Journal de neuroradiologie10 citations Open access
Semantic Scholar
Modeling MOG Antibody–Associated Disorder and Neuromyelitis Optica Spectrum Disorder in Animal Models
J. Remlinger, Maud Bagnoud, Ivo Meli, Marine Massy +6 more
2023Neurology: Neuroimmunology & Neuroinflammation10 citations Open access
Semantic Scholar
Submillimeter T1 atlas for subject‐specific abnormality detection at 7T
G. Piredda, Samuele Caneschi, T. Hilbert, G. Bonanno +20 more
2022Magnetic Resonance in Medicine10 citations Open access
Semantic Scholar
Contrast-Enhancing Lesion Segmentation in Multiple Sclerosis: A Deep Learning Approach Validated in a Multicentric Cohort
Martina Greselin, Po-Jui Lu, L. Melie-García, M. Ocampo-Pineda +34 more
2024Bioengineering9 citations Open access
Semantic Scholar
Association of Disease-Modifying Treatment With Outcome in Patients With Relapsing Multiple Sclerosis and Isolated MRI Activity
G. Bsteh, M. L. Aicher, Janette Walde, N. Krajnc +22 more
2024Neurology9 citations
Semantic Scholar
ECTRIMS 2024 – Late Breaking Oral Presentations
A. Abdelhak, A. Maceski, S. Schädelin, Eline Willemse +191 more
2024Multiple Sclerosis9 citations
Semantic Scholar
Multiple sclerosis as a model to investigate SARS‐CoV‐2 effect on brain atrophy
Michael Rebsamen, C. Friedli, Piotr Radojewski, L. Diem +5 more
2022CNS Neuroscience & Therapeutics9 citations Open access
Semantic Scholar
No optical coherence tomography changes in premanifest Huntington's disease mutation carriers far from disease onset
Rahel Dominique Schmid, J. Remlinger, M. Abegg, R. Hoepner +4 more
2022Brain and Behavior9 citations Open access
Semantic Scholar
Humoral and cellular responses to mRNA vaccines against SARS-CoV2 in patients with a history of CD20-B-cell depleting therapy
M. Moor, F. Suter-Riniker, M. Horn, D. Aeberli +16 more
2021medRxiv9 citations Open access
Semantic Scholar
Comparative effectiveness of teriflunomide and ocrelizumab on smoldering activity in multiple sclerosis: an observational study in the Swiss Multiple Sclerosis Cohort
A. Cagol, S. Schaedelin, M. Ocampo-Pineda, P. Benkert +30 more
2025Journal of Neurology8 citations Open access
Semantic Scholar
Recommendations for the Treatment of Multiple Sclerosis in Family Planning, Pregnancy and Lactation in Switzerland: Immunotherapy
Michael Graber, A. Panchaud, Hélène Legardeur, T. Derfuss +19 more
2024Clinical and Translational Neuroscience8 citations Open access
Semantic Scholar
MultiSCRIPT-Cycle 1—a pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment decisions in multiple sclerosis: a study protocol for a randomized clinical trial
P. Janiaud, C. Zecca, A. Salmen, P. Benkert +25 more
2024Trials7 citations Open access
Semantic Scholar
Modelling MOG antibody-associated disorder and neuromyelitis optica spectrum disorder in animal models: Spinal cord manifestations
J. Remlinger, Maud Bagnoud, Ivo Meli, Marine Massy +6 more
2023Multiple Sclerosis and Related Disorders7 citations Open access
Semantic Scholar
Anti‐neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia—a case report and review of the literature
Anina Schwarzwald, A. Salmen, Alejandro Xavier León Betancourt, L. Diem +7 more
2022European Journal of Neurology7 citations Open access
Semantic Scholar
Serum GFAP as a biomarker for progression in multiple sclerosis: assay comparison and a large reference database of healthy controls
Eline Willemse, S. Sandgren, P. Benkert, S. Schaedelin +22 more
2025Clinical Chemistry and Laboratory Medicine6 citations Open access
Semantic Scholar
Different lymphocyte counts of multiple sclerosis patients treated with ofatumumab and ocrelizumab: A retrospective observational study
C. Friedli, N. Krajnc, H. Hammer, Stefanie Marti +8 more
2024Journal of Central Nervous System Disease6 citations Open access
Semantic Scholar
Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse events
Pauline Thränhardt, Admirim Veselaj, C. Friedli, F. Wagner +8 more
2024Therapeutic Advances in Neurological Disorders6 citations Open access
Semantic Scholar
Longitudinal analysis of antibody trajectories and humoral responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy (RituxiVac 2.0)
D. Sidler, A. Born, Simeon Schietzel, M. Horn +20 more
2021medRxiv6 citations Open access
Semantic Scholar
Towards Supporting an Early Diagnosis of Multiple Sclerosis using Vocal Features
Monica Gonzalez-Machorro, Pascal Hecker, Uwe D. Reichel, H. Hammer +9 more
2023Interspeech5 citations
Semantic Scholar
Socioeconomic and Regional Disparities in Industry-Sponsored Clinical Trials in Multiple Sclerosis
Stefanie Marti, Andreas G. F. Hoepner, H. Hammer, A. Salmen +2 more
2023JAMA Network Open5 citations Open access
Semantic Scholar
Effect of Season of Birth on Hippocampus Volume in a Transdiagnostic Sample of Patients With Depression and Schizophrenia
N. Schaub, Nina Ammann, Frauke Conring, T. Müller +5 more
2022Frontiers in Human Neuroscience5 citations Open access
Semantic Scholar
The Real-World Experiences of Persons With Multiple Sclerosis During the First COVID-19 Lockdown: Application of Natural Language Processing
Deborah Chiavi, C. Haag, A. Chan, C. Kamm +16 more
2022JMIR Medical Informatics5 citations Open access
Semantic Scholar
Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System
M. Pistor, R. Hoepner, Andreas G. F. Hoepner, Yanan Lin +4 more
2022Therapeutic Advances in Neurological Disorders5 citations Open access
Semantic Scholar
Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity
S. Sandgren, A. Maceski, P. Benkert, M. Einsiedler +21 more
2025Multiple Sclerosis4 citations Open access
Semantic Scholar
Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcome
G. Bsteh, R. Hoepner, J. A. Gernert, K. Berek +20 more
2024European Journal of Neurology4 citations Open access
Semantic Scholar
Disability progression is a question of definition-A methodological reappraisal by example of primary progressive multiple sclerosis.
G. Bsteh, Stefanie Marti, N. Krajnc, Gerhard Traxler +9 more
2024Multiple Sclerosis and Related Disorders4 citations Open access
Semantic Scholar
Human endogenous retrovirus type-W and multiple sclerosis–related smoldering neuroinflammation
J. Gruchot, L. Reiche, A. Chan, R. Hoepner +1 more
2024Neural Regeneration Research4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Salmen×28
Invite
A. Salmen — researcher profile on SciRah
H. Hammer×17
Invite
H. Hammer — researcher profile on SciRah
C. Pot×14
Invite
C. Pot — researcher profile on SciRah
C. Gobbi×14
Invite
C. Gobbi — researcher profile on SciRah

×13

Invite

C. Zecca — researcher profile on SciRah

C. Granziera×13

Invite

C. Granziera — researcher profile on SciRah

Invite

P. Benkert — researcher profile on SciRah

Invite

S. Müller — researcher profile on SciRah

Invite

L. Diem — researcher profile on SciRah

Invite

C. Friedli — researcher profile on SciRah

J. Oechtering×11

Invite

J. Oechtering — researcher profile on SciRah

Invite

P. Lalive — researcher profile on SciRah